Market Overview:
The global viral clearance market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in this market can be attributed to the increasing demand for recombinant proteins, blood and blood products, and vaccines. In addition, the growing awareness about viral safety among consumers is also contributing to the growth of this market. On the basis of type, the global viral clearance market can be segmented into viral removal, chromatography, nanofiltration, precipitation, vira inactivation methods (low pH methodologies and solvent detergent method), pasteurization methods (high temperature short time [HTST] pasteurization and ultra-high temperature [UHT] pasteurization), and other vira inactivation methods.
Product Definition:
A viral clearance is the process of ensuring that a virus has been eliminated from a product or production line. This is important to ensure the safety of consumers.
Viral Removal:
Viral removal is a process in which the viral load is reduced to an acceptable level. Viral load refers to the number of viruses present in a specimen of body fluid such as blood, semen, vaginal fluids or swab samples. The normal range for viral count varies from 1e-5 to 5e-7 per milliliter with an average count of 2e-4to 4e-6 per milliliter.
Chromatography:
Chromatography is a technique used for the separation of compounds according to their molecular weight. It is also used in the purification of materials and analysis of chemical compounds. The process involves using a solvent, which acts as an agent to separate the components on the basis of their polarities and different mobilities.
Application Insights:
The other applications segment includes vaccines, cell culture, biopharmaceuticals and other products. The recombinant proteins segment dominated the application market in 2017 owing to the rising demand for protein drugs. This is attributed to factors such as increasing investments by companies for research & development activities in this sector and growing emphasis on viral clearance techniques that are used during production of these products.
The blood and blood products segment is anticipated to witness lucrative growth over the forecast period due to factors such as an increase in surgeries, accidents & trauma cases leading to a rise in demand for fresh frozen plasma (FFP), plateletpheresis (PP) and related therapies globally which further drives viral clearance techniques usage during FFP, PP or any other type of therapeutic protein production process.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of viral clearance facilities, higher adoption rate of advanced technologies and increasing demand for vaccines & other biologics. The U.S., which is at the forefront, has witnessed several outbreaks of COVID-19 recently that have led to an increase in demand for virus clearance solutions from this region as well as others (Asia Pacific and Latin America).
The Asia Pacific regional market is expected to grow at a lucrative pace over the forecast period owing to factors such as growing awareness about emerging infectious diseases, rising disposable income coupled with increased access among people especially in developing countries such as India & China regarding these products resulting into high demand across industries including agriculture, food processing etc.). Furthermore, government initiatives are undertaken by various countries including Japan and Australia aimed towards strengthening their national healthcare systems are anticipated to boost growth during forecast years.
Growth Factors:
- Increasing incidence of viral infections: The global incidence of viral infections is increasing due to the growing population and the spread of viruses through travel. This is driving the demand for viral clearance products and services.
- Growing awareness about viral clearance products: There is a growing awareness among consumers about the benefits of using viral clearance products and services. This is helping to drive growth in the market.
- Technological advancements: The development of new technologies that can help to improve the efficiency and speed of virus detection and removal is helping to drive growth in this market.
- Rising demand from emerging markets: The demand for virus detection and removal products is rising rapidly in emerging markets such as China, India, Brazil, etc., due to increasing economic development and rising incomes levels there.. This is providing opportunities for growth in this market segment.. 5
Scope Of The Report
Report Attributes
Report Details
Report Title
Viral Clearance Market Research Report
By Type
Viral Removal, Chromatography, Nanofiltration, Precipitation, Viral Inactivation, Low pH, Solvent Detergent Method, Pasteurization, Other Viral Inactivation Methods
By Application
Recombinant Proteins, Blood and Blood Products, Vaccines, Other Applications
By Companies
Wuxi Biologics (Cayman), Merck, Charles River Laboratories International, Kedrion, Vironova Biosafety, Texcell, Clean Cells
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
175
Number of Tables & Figures
123
Customization Available
Yes, the report can be customized as per your need.
Global Viral Clearance Market Report Segments:
The global Viral Clearance market is segmented on the basis of:
Types
Viral Removal, Chromatography, Nanofiltration, Precipitation, Viral Inactivation, Low pH, Solvent Detergent Method, Pasteurization, Other Viral Inactivation Methods
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Recombinant Proteins, Blood and Blood Products, Vaccines, Other Applications
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Wuxi Biologics (Cayman)
- Merck
- Charles River Laboratories International
- Kedrion
- Vironova Biosafety
- Texcell
- Clean Cells
Highlights of The Viral Clearance Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Viral Removal
- Chromatography
- Nanofiltration
- Precipitation
- Viral Inactivation
- Low pH
- Solvent Detergent Method
- Pasteurization
- Other Viral Inactivation Methods
- By Application:
- Recombinant Proteins
- Blood and Blood Products
- Vaccines
- Other Applications
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Viral Clearance Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Viral clearance is the process by which viruses are eliminated from the body. Viruses are eliminated through a variety of methods, including the immune system's ability to fight off infection, and excretion through urine and feces.
Some of the major players in the viral clearance market are Wuxi Biologics (Cayman), Merck, Charles River Laboratories International, Kedrion, Vironova Biosafety, Texcell, Clean Cells.
The viral clearance market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Viral Clearance Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Viral Clearance Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Viral Clearance Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Viral Clearance Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Viral Clearance Market Size & Forecast, 2018-2028
4.5.1 Viral Clearance Market Size and Y-o-Y Growth
4.5.2 Viral Clearance Market Absolute $ Opportunity
Chapter 5 Global Viral Clearance Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Viral Clearance Market Size Forecast by Type
5.2.1 Viral Removal
5.2.2 Chromatography
5.2.3 Nanofiltration
5.2.4 Precipitation
5.2.5 Viral Inactivation
5.2.6 Low pH
5.2.7 Solvent Detergent Method
5.2.8 Pasteurization
5.2.9 Other Viral Inactivation Methods
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Viral Clearance Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Viral Clearance Market Size Forecast by Applications
6.2.1 Recombinant Proteins
6.2.2 Blood and Blood Products
6.2.3 Vaccines
6.2.4 Other Applications
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Viral Clearance Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Viral Clearance Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Viral Clearance Analysis and Forecast
9.1 Introduction
9.2 North America Viral Clearance Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Viral Clearance Market Size Forecast by Type
9.6.1 Viral Removal
9.6.2 Chromatography
9.6.3 Nanofiltration
9.6.4 Precipitation
9.6.5 Viral Inactivation
9.6.6 Low pH
9.6.7 Solvent Detergent Method
9.6.8 Pasteurization
9.6.9 Other Viral Inactivation Methods
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Viral Clearance Market Size Forecast by Applications
9.10.1 Recombinant Proteins
9.10.2 Blood and Blood Products
9.10.3 Vaccines
9.10.4 Other Applications
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Viral Clearance Analysis and Forecast
10.1 Introduction
10.2 Europe Viral Clearance Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Viral Clearance Market Size Forecast by Type
10.6.1 Viral Removal
10.6.2 Chromatography
10.6.3 Nanofiltration
10.6.4 Precipitation
10.6.5 Viral Inactivation
10.6.6 Low pH
10.6.7 Solvent Detergent Method
10.6.8 Pasteurization
10.6.9 Other Viral Inactivation Methods
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Viral Clearance Market Size Forecast by Applications
10.10.1 Recombinant Proteins
10.10.2 Blood and Blood Products
10.10.3 Vaccines
10.10.4 Other Applications
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Viral Clearance Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Viral Clearance Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Viral Clearance Market Size Forecast by Type
11.6.1 Viral Removal
11.6.2 Chromatography
11.6.3 Nanofiltration
11.6.4 Precipitation
11.6.5 Viral Inactivation
11.6.6 Low pH
11.6.7 Solvent Detergent Method
11.6.8 Pasteurization
11.6.9 Other Viral Inactivation Methods
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Viral Clearance Market Size Forecast by Applications
11.10.1 Recombinant Proteins
11.10.2 Blood and Blood Products
11.10.3 Vaccines
11.10.4 Other Applications
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Viral Clearance Analysis and Forecast
12.1 Introduction
12.2 Latin America Viral Clearance Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Viral Clearance Market Size Forecast by Type
12.6.1 Viral Removal
12.6.2 Chromatography
12.6.3 Nanofiltration
12.6.4 Precipitation
12.6.5 Viral Inactivation
12.6.6 Low pH
12.6.7 Solvent Detergent Method
12.6.8 Pasteurization
12.6.9 Other Viral Inactivation Methods
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Viral Clearance Market Size Forecast by Applications
12.10.1 Recombinant Proteins
12.10.2 Blood and Blood Products
12.10.3 Vaccines
12.10.4 Other Applications
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Viral Clearance Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Viral Clearance Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Viral Clearance Market Size Forecast by Type
13.6.1 Viral Removal
13.6.2 Chromatography
13.6.3 Nanofiltration
13.6.4 Precipitation
13.6.5 Viral Inactivation
13.6.6 Low pH
13.6.7 Solvent Detergent Method
13.6.8 Pasteurization
13.6.9 Other Viral Inactivation Methods
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Viral Clearance Market Size Forecast by Applications
13.10.1 Recombinant Proteins
13.10.2 Blood and Blood Products
13.10.3 Vaccines
13.10.4 Other Applications
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Viral Clearance Market: Competitive Dashboard
14.2 Global Viral Clearance Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Wuxi Biologics (Cayman)
14.3.2 Merck
14.3.3 Charles River Laboratories International
14.3.4 Kedrion
14.3.5 Vironova Biosafety
14.3.6 Texcell
14.3.7 Clean Cells
